COMT Activity and Hypnotizability
Public ClinicalTrials.gov record NCT04624880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
COMT Activity as a Biomarker for Hypnotizability and Hypnotic Analgesia Using a Multiplexed Precision Medicine Platform
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Hypnosis is an effective pain management tool for surgery that can reduce opioid use up to 40%. COMT single nucleotide polymorphisms (SNPs) can predict pain sensitivity and opioid use perioperatively, and may also be associated with hypnotizability or response to hypnotic analgesia. Analyzing COMT haplotypes from DNA extracted from saliva or blood using a giant magnetoresistive (GMR) nanotechnology platform may be faster, less expensive, and at least as accurate as pyrosequencing. This study aims to validate a multi-SNP point-of-care (POC) GMR assay for the rapid genotyping of SNPs predictive of COMT activity, and test the feasibility of using COMT activity as a biomarker for hypnotizability and/or response to hypnotic analgesia.
Study identification
- NCT ID
- NCT04624880
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2021
- Primary completion
- Jul 3, 2021
- Completion
- Jul 12, 2021
- Last update posted
- Apr 8, 2026
2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University/Stanford Healthcare | Palo Alto | California | 94305 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Pain, Postoperative trials
Other public records listing Pain, Postoperative. Sorted by last update posted; newest first. Not a recommendation.
- NCT05400382: Maternal Mindfulness: Depression and Postpartum Pain Recruiting
- NCT07731295: iPAWS: Improving Pain Management After Wisdom Tooth Extraction Surgery Recruiting
- NCT07517679: Methadone for Post-operative Spine Surgery Recruiting
- NCT07689162: Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia Not yet recruiting
- NCT03737604: TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant Active, not recruiting
- NCT05415384: Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04624880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04624880 live on ClinicalTrials.gov.